An open-label, single-dose, parallel-group, dose-increasing study comparing the pharmacokinetics and tolerability of pilsicainide hydrochloride in healthy Korean and Japanese male subjects
2009 ◽
Vol 31
(3)
◽
pp. 609-618
◽
Keyword(s):